Background: It would be advantageous for the treatment of neonatal respiratory distress syndrome if effective amounts of surfactant could be delivered by nebulization. Objective: To investigate lung deposition and distribution of nebulized porcine surfactant using an investigational eFlow® neonatal nebulizer. Methods: While lying on one side, 1-day-old piglets inhaled 200 mg·kg-1 of nebulized surfactant via mask, nasal prongs, or tracheal tube. The surfactant was diluted with normal saline to 40 mg·ml-1 and labeled with 99mtechnetium-labelled nanocolloid. Undiluted surfactant (80 mg·ml-1) was instilled tracheally in a fourth group. Each group had 8 animals. Lung deposition was measured by gamma scintigraphy, and deposition values were presented as a percentage of the nebulized or instilled dose. Results: The median lung deposition of inhaled surfactant was 5% (range 3-16) via mask, 14% (2-40) via prongs, and 45% (25-56) via tracheal tube (p < 0.05). It was 88% (71-96) with instillation. In all groups, the surfactant preferentially went to the dependent lung. Deposition ratios (upper lung/both lungs) were 0.32 (0.13-0.58), 0.15 (0.05-0.58), 0.16 (0.11-0.23), and 0.08 (0.03-0.46). Conclusions: Using this nebulizer, the lung depositions of porcine surfactant were 45% via endotracheal tube and 14% via nasal-continuous positive airway pressure (prongs). These figures might be physiologically relevant, but still have to be confirmed in efficacy studies.

Keywords:
Nebulization, Neonatal respiratory distress syndrome, Surfactant
1.
Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, Saugstad OD, Simeoni U, Speer CP, Vento M, Halliday HL; European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2013 update. Neonatology 2013;103:353-368.
2.
Kaiser JR, Gauss CH, Williams DK: Surfactant administration acutely affects cerebral and systemic hemodynamics and gas exchange in very-low-birth-weight infants. J Pediatr 2004;144:809-814.
3.
Ellyett KM, Broadbent RS, Fawcett ER, Campbell AJ: Surfactant aerosol treatment of respiratory distress syndrome in the spontaneously breathing premature rabbit. Pediatr Res 1996;39:953-957.
4.
Henry MD, Rebello CM, Ikegami M, Jobe AH, Langenback EG, Davis JM: Ultrasonic nebulized in comparison with instilled surfactant treatment of preterm lambs. Am J Respir Crit Care Med 1996;154:366-375.
5.
Lewis JF, Ikegami M, Jobe AH, Tabor B: Aerosolized surfactant treatment of preterm lambs. J Appl Physiol 1991;70:869-876.
6.
Jorch G, Hartl H, Roth B, Kribs A, Gortner L, Schaible T, Hennecke KH, Poets C: Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants. Pediatr Pulmonol 1997;24:222-224.
7.
Berggren E, Liljedahl M, Winbladh B, Andreasson B, Curstedt T, Robertson B, Schollin J: Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr 2000;89:460-464.
8.
Finer NN, Merritt TA, Bernstein G, Job L, Mazela J, Segal R: An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonates. J Aerosol Med Pulm Drug Deliv 2010;23:303-309.
9.
Fok TF, al-Essa M, Dolovich M, Rasid F, Kirpalani H: Nebulisation of surfactants in an animal model of neonatal respiratory distress. Arch Dis Child Fetal Neonatal Ed 1998;78:F3-F9.
10.
Lewis JF, Tabor B, Ikegami M, Jobe AH, Joseph M, Absolom D: Lung function and surfactant distribution in saline-lavaged sheep given instilled vs. nebulized surfactant. J Appl Physiol (1985) 1993;74:1256-1264.
11.
Lass JS, Sant A, Knoch M: New advances in aerosolised drug delivery: vibrating membrane nebuliser technology. Expert Opin Drug Deliv 2006;3:693-702.
12.
Minocchieri S, Knoch S, Schoel WM, Ochs M, Nelle M: Nebulizing poractant alfa versus conventional instillation: ultrastructural appearance and preservation of surface activity. Pediatr Pulmonol 2014;49:348-356.
13.
Pillow JJ, Minocchieri S: Innovation in surfactant therapy II: surfactant administration by aerosolization. Neonatology 2012;101:337-344.
14.
Griese M, Bufler P, Teller J, Reinhardt D: Nebulization of a bovine surfactant in cystic fibrosis: a pilot study. Eur Respir J 1997;10:1989-1994.
15.
Rahmel DK, Pohlmann G, Iwatschenko P, Volland J, Liebisch S, Kock H, Mecklenburg L, Maurer C, Kemkowski J, Taut FJ: The non-intubated, spontaneously breathing, continuous positive airway pressure (CPAP) ventilated pre-term lamb: a unique animal model. Reprod Toxicol 2012;34:204-215.
16.
Rey-Santano C, Mielgo VE, Andres L, Ruiz-del-Yerro E, Valls-i-Soler A, Murgia X: Acute and sustained effects of aerosolized vs. bolus surfactant therapy in premature lambs with respiratory distress syndrome. Pediatr Res 2013;73:639-646.
17.
Broadbent R, Fok TF, Dolovich M, Watts J, Coates G, Bowen B, Kirpalani H: Chest position and pulmonary deposition of surfactant in surfactant depleted rabbits. Arch Dis Child Fetal Neonatal Ed 1995;72:F84-F89.
18.
Dijk PH, Heikamp A, Bambang Oetomo S: Surfactant nebulisation: lung function, surfactant distribution and pulmonary blood flow distribution in lung lavaged rabbits. Intensive Care Med 1997;23:1070-1076.
19.
Newman S, Bennett WD, Biddiscombe M, Devadason SG, Dolovich MB, Fleming J, Haeussermann S, Kietzig C, Kuehl PJ, Laube BL, Sommerer K, Taylor G, Usmani OS, Zeman KL: Standardization of techniques for using planar (2D) imaging for aerosol deposition assessment of orally inhaled products. J Aerosol Med Pulm Drug Deliv 2012;25(suppl 1):S10-S28.
20.
Amirav I, Newhouse MT: Deposition of small particles in the developing lung. Paediatr Respir Rev 2012;13:73-78.
21.
Newman SP: Aerosols; in Laurent GJ, Shapiro SD (eds): Encyclopedia of Respiratory Medicine. Amsterdam, Elsevier, 2006, pp 58-64.
22.
Karrasch S, Eder G, Bolle I, Tsuda A, Schulz H: Breath-by-breath measurement of particle deposition in the lung of spontaneously breathing rats. J Appl Physiol 2009;107:1293-1299.
23.
Mulrooney N, Champion Z, Moss TJ, Nitsos I, Ikegami M, Jobe AH: Surfactant and physiologic responses of preterm lambs to continuous positive airway pressure. Am J Respir Crit Care Med 2005;171:488-493.
24.
Marks LB, Notter RH, Oberdorster G, McBride JT: Ultrasonic and jet aerosolization of phospholipids and the effects on surface activity. Pediatr Res 1983;17:742-747.
25.
Wagner MH, Amthauer H, Sonntag J, Drenk F, Eichstadt HW, Obladen M: Endotracheal surfactant atomization: an alternative to bolus instillation? Crit Care Med 2000;28:2540-2544.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.